Cipher Pharmaceuticals Stock Forecast - Price Action Indicator
| CPH Stock | CAD 14.75 0.05 0.34% |
Cipher Stock outlook is based on your current time horizon. Although Cipher Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Cipher Pharmaceuticals' systematic risk associated with finding meaningful patterns of Cipher Pharmaceuticals fundamentals over time.
As of today, the relative strength index (RSI) of Cipher Pharmaceuticals' share price is approaching 49 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Cipher Pharmaceuticals, making its price go up or down. Momentum 49
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 20 | EPS Estimate Next Quarter 0.295 | EPS Estimate Current Year 0.9667 | EPS Estimate Next Year 0.761 | Wall Street Target Price 19.2 |
Using Cipher Pharmaceuticals hype-based prediction, you can estimate the value of Cipher Pharmaceuticals from the perspective of Cipher Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
Cipher Pharmaceuticals after-hype prediction price | CAD 14.74 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cipher |
Cipher Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Cipher price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cipher using various technical indicators. When you analyze Cipher charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 0.035 | (0.07) |
| Check Cipher Pharmaceuticals Volatility | Backtest Cipher Pharmaceuticals | Information Ratio |
Cipher Pharmaceuticals Trading Date Momentum
| On January 27 2026 Cipher Pharmaceuticals was traded for 14.75 at the closing time. The maximum traded price for the trading interval was 14.85 and the lowest daily price was 14.75 . The daily volume was recorded at 13.9 K. The volume of trading on 27th of January 2026 did not affect price variability. The overall trading delta to the closing price today is 0.14% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Cipher Pharmaceuticals to competition |
Other Forecasting Options for Cipher Pharmaceuticals
For every potential investor in Cipher, whether a beginner or expert, Cipher Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cipher Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cipher. Basic forecasting techniques help filter out the noise by identifying Cipher Pharmaceuticals' price trends.Cipher Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cipher Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Cipher Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Cipher Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cipher Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Cipher Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cipher Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Cipher Pharmaceuticals stock market strength indicators, traders can identify Cipher Pharmaceuticals entry and exit signals to maximize returns.
Cipher Pharmaceuticals Risk Indicators
The analysis of Cipher Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cipher Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cipher stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.4 | |||
| Semi Deviation | 2.08 | |||
| Standard Deviation | 2.11 | |||
| Variance | 4.45 | |||
| Downside Variance | 4.8 | |||
| Semi Variance | 4.31 | |||
| Expected Short fall | (1.50) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cipher Pharmaceuticals
The number of cover stories for Cipher Pharmaceuticals depends on current market conditions and Cipher Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cipher Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cipher Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Cipher Pharmaceuticals Short Properties
Cipher Pharmaceuticals' future price predictability will typically decrease when Cipher Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cipher Pharmaceuticals often depends not only on the future outlook of the potential Cipher Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cipher Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 24.6 M | |
| Cash And Short Term Investments | 17.8 M |
Other Information on Investing in Cipher Stock
Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.